CareDx (CDNA) Q2 Update: 12.8% YTD Growth, Modest 0.07% Gain Amid Volatility
Explore CareDx’s latest trading snapshot: modest price lift, 12.8% YTD gain, and how its niche heart‑transplant diagnostics compare to peers.
2 minutes to read
CAREDX INC
CareDx Shares Dip 2.23% as AlloSure Kidney Platform Strengthens Market Position
CareDx (CDNA) trades near its 52‑week high after announcing dd‑cfDNA trials that cut biopsies for kidney transplants—an attractive move for investors eyeing non‑invasive monitoring tech.
3 minutes to read